Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

189.69 -2.66 (-1.38%)
Official Closing Price Updated: 4:10 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces ↗
Telehealth company eMed and Quest Diagnostics Inc (NYSE: DGX) have collaborated for clinician-guided rapid antigen testing for COVID-19 in... 
Via Benzinga
News headline image
Price To Earnings Ratio Insights For Quest Diagnostics ↗
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $149.29, after a 0.48% gain. Over the past month, the stock increased by 10.83%, and in the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Understanding Quest Diagnostics's Ex-Dividend Date ↗
On May 20, 2021, Quest Diagnostics (NYSE:DGX) announced shar... 
Via Benzinga
News headline image
Quest Diagnostics Keeps Slumping, Here’s The Trade ↗
Quest Diagnostics Inc stock has excellent support around the $118.00 level. This support area is where the stock broke out to the upside back in March 2021. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
Healthcare Services IPO Agiliti Stock Sees Improved Relative Strength ↗
Agiliti shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Topics Initial Public Offering
News headline image
Is This Diagnostics Company a Buy After Blowing Away Earnings Estimates? ↗
Quest Diagnostics was the beneficiary of a faster than expected recovery in its base business in the second quarter. 
Via The Motley Fool
News headline image
Quest Diagnostics Inc (DGX) Q2 2021 Earnings Call Transcript ↗
DGX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance ↗
Quest Diagnostics Incorporated (NYSE: DGX) posted better-than-expected second-quarter results, as vaccinations and the lifting of lockdowns resulted in recovery in its... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
News headline image
Quest Diagnostics: Q2 Earnings Insights ↗
Shares of Quest Diagnostics (NYSE:DGX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share rose 123.94% year over year to $3.18,... 
Via Benzinga
News headline image
Earnings Preview: Quest Diagnostics ↗
On Thursday, July 22, Quest Diagnostics (NYSE:DGX) will release its latest earnings report. Benzinga's outlook for Quest Diagnostics is included in the following report. What Are... 
Via Benzinga
News headline image
Quest Diagnostics's Earnings: A Preview ↗
Quest Diagnostics (NYSE:DGX) will be releasing its next round of earnings this Thursday, July 22. For all of the relevant information, here is your guide for Thursday's Q2... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs ↗
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,... 
Via Talk Markets
News headline image
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs ↗
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week... 
Via Benzinga
News headline image
Earnings Scheduled For July 22, 2021 ↗
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,... 
Via Benzinga
News headline image
30 Firms Going Ex-Dividend Next Week, Including AT&T, Comcast And Verizon Communications ↗
There are several well known large cap stocks going ex-dividend next week including six Top 100 Dividend Stocks: Sempra Energy, Quest Diagnostics, Comcast, AT&T, Verizon Communications and Hormel... 
Via Talk Markets
News headline image
Lots Of Bearish Sentiment Toward Quest Diagnostics, And That Could Help The Stock Move Higher ↗
Quest Diagnostics has been trending higher for the last 16 months and a trend channel has formed that helps define the different cycles within the overall trend. Analysts and short sellers are... 
Via Talk Markets
News headline image
Quest Diagnostics Releases Annual Corporate Responsibility Report
SOURCE: 3BL Alerts 
Via 3BL Media
News headline image
Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients ↗
Biocept Inc (NASDAQ: BIOC) has collaborated with Quest Diagnostics Inc (NYSE: DGX) to provide laboratory testing services to Quest patients for its Target... 
Via Benzinga
News headline image
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
From Biocept, Inc.
Via Business Wire
News headline image
2 Incredibly Cheap Healthcare Stocks ↗
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
IBD Rating Upgrades: Laboratory Corporation Of America Key Stock Rating Climbs Amid 279% Profit Growth On 47% Sales Surge ↗
The 73 RS Rating means Labcorp has outperformed 73% of all stocks over the past year. It's good but not great. However, other key ratings are outstanding. 
Via Investor's Business Daily
News headline image
Agiliti Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ↗
Agiliti stock had its Relative Strength Rating upgraded from 80 to 85 Tuesday. An RS Rating over the key 80 benchmark makes Agiliti a stock to watch. 
Via Investor's Business Daily
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.